NASDAQ · NOVT
Technology · Hardware, Equipment & Parts
$149.10
Down-$1.51 (-1.00%)
Updated Oct 7, 2026, 6:15 AM
SID Score
5.6/10
Composite research score
Smart Money
62/100
Neutral
Price performance · NOVT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
NOVT closed at $149.10 after 21 trading sessions, down 0.14% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $151.87 | $153.67 | $148.675 | $149.10 | 418.94K |
| Oct 5, 2026 | $149.07 | $151.63 | $145.82 | $150.61 | 335.49K |
| Oct 2, 2026 | $146.51 | $151.73 | $146.51 | $149.27 | 367.61K |
| Oct 1, 2026 | $142.30 | $145.25 | $140.00 | $143.58 | 246.76K |
| Sep 30, 2026 | $141.78 | $143.85 | $140.615 | $142.19 | 440.82K |
| Sep 29, 2026 | $143.50 | $144.86 | $140.61 | $141.22 | 190.19K |
| Sep 28, 2026 | $142.40 | $143.335 | $140.27 | $142.08 | 298.97K |
| Sep 25, 2026 | $142.28 | $145.24 | $140.57 | $143.93 | 287.88K |
| Sep 24, 2026 | $143.75 | $143.79 | $139.77 | $141.53 | 250.42K |
| Sep 23, 2026 | $143.42 | $146.00 | $141.09 | $144.43 | 370.78K |
| Sep 22, 2026 | $136.91 | $144.41 | $135.08 | $144.17 | 776.79K |
| Sep 21, 2026 | $134.05 | $135.52 | $132.00 | $134.31 | 321.56K |
| Sep 18, 2026 | $134.35 | $134.765 | $130.67 | $133.14 | 808.46K |
| Sep 17, 2026 | $136.68 | $137.91 | $133.457 | $133.55 | 406.24K |
| Sep 16, 2026 | $138.54 | $139.33 | $130.84 | $132.80 | 473.17K |
| Sep 15, 2026 | $141.40 | $141.40 | $137.81 | $138.23 | 401.38K |
| Sep 14, 2026 | $142.63 | $142.80 | $139.11 | $140.05 | 340.53K |
| Sep 11, 2026 | $146.41 | $149.00 | $146.075 | $146.56 | 257.25K |
| Sep 10, 2026 | $143.72 | $146.125 | $142.476 | $143.91 | 183.32K |
| Sep 9, 2026 | $148.02 | $150.88 | $145.55 | $145.76 | 291.24K |
| Sep 8, 2026 | $148.36 | $153.155 | $147.98 | $149.31 | 304.98K |
The latest Smart Investors Daily articles mentioning NOVT.
Company
Market Activity
Research & News
NOVT research
Company profile and research snapshot.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 13, 2026 | Baird | Outperform | — |
| Mar 30, 2026 | Baird | Outperform | — |
| Aug 11, 2025 | Baird | Neutral | — |
| Mar 3, 2025 | Baird | Neutral | — |
| Nov 6, 2024 | Baird | Neutral | — |
No generated briefing is available yet.
Benzinga · Oct 1, 2026
Novanta (NASDAQ:NOVT) has outperformed the market over the past 15 years by 8.22% on an annualized basis producing an average annual return of 21.59%. Currently, Novanta has a market capitalization of $5.13 billion.
ChartMill · Sep 10, 2026
Novanta (NOVT) passes key quality tests—strong EBIT growth, 22.9% core ROIC, low debt—but valuation and margin trends warrant caution.
Benzinga · Sep 7, 2026
Novanta (NASDAQ:NOVT) has outperformed the market over the past 15 years by 7.74% on an annualized basis producing an average annual return of 21.09%. Currently, Novanta has a market capitalization of $5.28 billion.
SeekingAlpha · Aug 23, 2026
Novanta completed the Riverpoint Medical acquisition, enhancing recurring consumables and medical business growth prospects.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NOVT.
